Inmedix was founded in 2006 by Andrew J Holman, MD, and Mr. Timothy Sciarrillo as a patent holding company for Dr. Holman's discoveries. Its first project addressed the treatment of fibromyalgia with dopamine agonists, medications FDA-approved for the treatment of Parkinson's disease.